1. Decoding mutational hotspots in human disease through the gene modules governing thymic regulatory T cells.
- Author
-
Raposo AASF, Rosmaninho P, Silva SL, Paço S, Brazão ME, Godinho-Santos A, Tokunaga-Mizoro Y, Nunes-Cabaço H, Serra-Caetano A, Almeida ARM, and Sousa AE
- Subjects
- Humans, Transcription Factors genetics, T-Lymphocytes, Regulatory immunology, T-Lymphocytes, Regulatory metabolism, Gene Regulatory Networks, Thymus Gland immunology, Thymus Gland metabolism, Mutation
- Abstract
Computational strategies to extract meaningful biological information from multiomics data are in great demand for effective clinical use, particularly in complex immune-mediated disorders. Regulatory T cells (Tregs) are essential for immune homeostasis and self-tolerance, controlling inflammatory and autoimmune processes in many diseases with a multigenic basis. Here, we quantify the Transcription Factor (TF) differential occupancy landscape to uncover the Gene Regulatory Modules governing lineage-committed Tregs in the human thymus, and show that it can be used as a tool to prioritise variants in complex diseases. We combined RNA-seq and ATAC-seq and generated a matrix of differential TF binding to genes differentially expressed in Tregs, in contrast to their counterpart conventional CD4 single-positive thymocytes. The gene loci of both established and novel genetic interactions uncovered by the Gene Regulatory Modules were significantly enriched in rare variants carried by patients with common variable immunodeficiency, here used as a model of polygenic-based disease with severe inflammatory and autoimmune manifestations. The Gene Regulatory Modules controlling the Treg signature can, therefore, be a valuable resource for variant classification, and to uncover new therapeutic targets. Overall, our strategy can also be applied in other biological processes of interest to decipher mutational hotspots in individual genomes., Competing Interests: Patent pending pertaining to the results in the paper, filed under nr. PT118969, on 10/10/2023, with AR, PR, and AS as co-inventors. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Raposo, Rosmaninho, Silva, Paço, Brazão, Godinho-Santos, Tokunaga-Mizoro, Nunes-Cabaço, Serra-Caetano, Almeida and Sousa.)
- Published
- 2024
- Full Text
- View/download PDF